OVA conjugated Leukemia inhibitory factor (LIF)
#
-
Catalog numberRPU50757-100ug
-
Price:
-
Size100ug
-
-
Estimated Turnaround Time6-11 business days
-
Gene NameNA
-
Alternative NamesCDF; D-FACTOR; HILDA; MLPLI; Cholinergic Differentiation Factor; Differentiation-Stimulating Factor; Melanoma-Derived LPL Inhibitor; Emfilermin
-
SourceChemical synthesis
-
Purity> 90%
-
ApplicationImmunogen; SDS-PAGE; WB
-
Shipping ConditionsIce packs
-
Storage conditionsShort term: -20°C; Long term: -80°C. Minimize freeze and thaw cycles.
-
Shelf life1 year
-
RestrictionFor research use only. Not for diagnostic procedures.
-
DescriptionAplha, transcription related growth factors and stimulating factors or repressing nuclear factors are complex subunits of proteins involved in cell differentiation. Complex subunit associated factors are involved in hybridoma growth, Eosinohils, eritroid proliferation and derived from promotor binding stimulating subunits on the DNA binding complex. NFKB 105 subunit for example is a polypetide gene enhancer of genes in B cells.
-
GeneOvalbumin (abbreviated OVA) is the main protein found in egg white, making up 60-65% of the total protein. Ovalbumin displays sequence and three-dimensional homology to the serpin superfamily, but unlike most serpins it is not a serine protease inhibitor. The function of ovalbumin is unknown, although it is presumed to be a storage protein. OVA is also the best characterized and the first antigen proteins used as a transgene to make transgenic mice. Many different transgenic mouse models have systemic OVA expression driven by the ubiquitously expressed b-actin promoter or tissue-specific OVA expression with insulin promoter to drive the transgene expression, for studying type I diabetes, or in different isoforms, secreted or cell-membrane associated, and more recently as inducible transgene models. These C57BL/6 mice, BALB/c mice models are well characterized, and have contributed to our understanding of immunogenicity and tolerance by the OVA model.
-
Gene target
-
Gene symbolLIF-AS1, LIF-AS2, LIF
-
Short nameOVA conjugated Leukemia inhibitory factor (LIF)
-
Techniqueantibody Conjugates
-
SpeciesSus scrofa; Porcine (Pig)
-
Alternative nameOVA coupled Leukemia inhibitory factor (leukemia inhibitory factor)
-
Alternative to gene targetleukemia inhibitory factor, CDF and DIA and HILDA and MLPLI, LIF and IDBG-3968 and ENSG00000128342 and 3976, growth factor activity, Extracellular, Lif and IDBG-142317 and ENSMUSG00000034394 and 16878, LIF and IDBG-636335 and ENSBTAG00000007424 and 280840
-
Virusleukemia
-
Gene info
-
Identity
-
Gene
-
Long gene nameLIF antisense RNA 1
-
Synonyms
-
Locus
-
Discovery year2017-04-28
-
Pubmed identfication
-
Classification
- Antisense RNAs
Gene info
-
Identity
-
Gene
-
Long gene nameLIF antisense RNA 2
-
Locus
-
Discovery year2020-10-07
-
Entrez gene record
-
RefSeq identity
-
Classification
- Antisense RNAs
Gene info
-
Identity
-
Gene
-
Long gene nameLIF interleukin 6 family cytokine
-
Synonyms gene name
- leukemia inhibitory factor
- LIF, interleukin 6 family cytokine
-
Synonyms
-
Synonyms name
-
Locus
-
Discovery year1989-06-11
-
Entrez gene record
-
Pubmed identfication
-
RefSeq identity
-
Classification
- Receptor ligands
- Interleukin 6 type cytokine family
-
VEGA ID
-
Locus Specific Databases
MeSH Data
-
Name
-
ConceptScope note: Leukemia induced experimentally in animals by exposure to leukemogenic agents, such as VIRUSES; RADIATION; or by TRANSPLANTATION of leukemic tissues.
-
Tree numbers
- C04.557.337.372
- C04.619.531
- E05.598.500.496.500
-
Qualifiersdiagnosis, parasitology, immunology, microbiology, diagnostic imaging, physiopathology, rehabilitation, enzymology, etiology, mortality, epidemiology, blood, cerebrospinal fluid, chemically induced, congenital, diet therapy, drug therapy, therapy, psychology, urine, virology, history, classification, economics, embryology, genetics, nursing, radiotherapy, ethnology, prevention & control, pathology, metabolism, complications, surgery